Alan Finkel, Chief Executive Officer of Axon Instruments, will become vice president and Chief Technology Officer of Molecular Devices, and Geoffrey Powell will retire as president of Axon once Molecular Devices' agreement to acquire Axon, announced March 21, is finalized. The transaction, in which Molecular Devices of Sunnyvale, Calif., is slated to acquire Axon, of Union City, Calif., and Melbourne, Australia for $140 million in cash and stock, is expected to close in early June, according to Molecular Devices.
Finkel founded Axon with his wife, Elizabeth Finkel, in 1983 to develop and sell instrumentation and software for cellular neurosciences and biophysical research. Since then the company has expanded into cell-based imaging and microarray scanning instrumentation.
James Glover has been named Chief Financial Officer of Beckman Coulter, the company said recently. Glover has been the company's interim CFO since August of 2003.
Glover joined Beckman Coulter in 1983. Since the beginning of 2003, he has served as vice president, controller and chief accounting officer. While at the company, he has led its capital restructuring and elimination of over $450 million in debt, as well as its risk management program and other efforts related to bond ratings and tax rate.
Glover, a certified public accountant, received his MBA from Pepperdine University and his BS in accounting from California State Polytechnic University.